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Background. Early-onset group B streptococcal (GBS) disease 
in neonates can be prevented by the use of intrapartum 
chemoprophylaxis. There are two prevention strategies, one 
based on risk factors and the other on culture screening for 
GBS. This study sought to establish whether GBS 
chemoprophylaxis is appropriate in a developing country 
such as South Africa. 
Methods. All neonates with early-onset GBS disease born at 
Johannesburg Hospital between 1 January 1995 and 
21 December 1997 were reviewed. Data were collected 
prospectively between 1 January and 31 October 1998. Data 
included demographic information, obstetric information, 
disease characteristics, admission details and mortality. The 
approximate cost of implementing both strategies was 
determined. 
Results. The overal incidence of early-onset GBS was 1.16 
per 1 000 live births. The rate was significantly greater in 
1998 compared with the previous years. Most of the babies 
were born preterm (70%), and 60% required admission to 
the neonatal intensive care unit (lCU) (a total of 81 ICU 
days). Twelve of the babies died. Assuming that 
chemoprophylaxis would reduce the number of ICU days 
by half, this would save an amount of R52 000. Culture-
based chemoprophylaxis would cost RIO million, whereas 
an approach based on risk factors would cost R31140. 
Conclusion. In conclusion, we feel that early-onset GBS 
disease is sufficiently prevalent in our unit to justify the 
implementation of a chemoprophylaxis strategy based on 
risk factors. Whether other units should adopt a similar 
approach would depend on the local incidence of early-
onset GBS. 
s Afr Med 1 2001; 91: 8.58-860. 
Group B streptococcus (GBS) is a common commensal of the 
maternal genito-urinary tract and colonises 15 - 40% of 
pregnant women. Early-onset GBS disease is associated with 
1 - 2 % of colonised mothers.' In infants, GBS disease is 
characterised as early-onset (i.e. occurring in infants < 7 days 
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old) or late-onset (i.e. occurring in infants ;::: 7 days old). Diseast 
in infants usually occurs as bacteraemia, pneumonia or 
meningitis.' Between 50% and 70% of the cases of neonatal GB~ 
disease occur in preterm infants. In 1990, GBS infection caused 
7 600 serious illnesses (incidence rate of 1.7/ 1 000 live births) 
and 310 deaths among US infants aged < 90 days; early-onset 
disease accounted for 80% of these illnesses.' The incidence of 
early-onset GBS disease in Oxford, England, between 1985 and 
1996, was reported as being 0.5/ 1 000 live births for definite 
early-onset infection and 0.4/ 1 000 for probable early-onset 
infection, giving a total of 0.9/ 1 000 live births.3 
Because a vaccine is not yet available, many neonatal 
infections can be prevented through the use of intrapartum 
antibiotic prophylaxis in women who are at risk of transmittin~ 
the infection to their newborns.' However, despite clinical trials 
that demonstrate the effectiveness of intrapartum antibiotic 
prophylaxis, prevention strategies have not been implemented 
widely or consistently, and the incidence of neonatal GBS 
disease has not declined .' 
In South Africa GBS is a significant cause of early-onset 
disease. The incidence of early-onset infections at Baragwanath 
Hospital during 1989 and 1990 was 1.9/1 000 live births, which 
was higher than the incidence quoted for the USA. • In a more 
recent survey, 21% of early-onset infections at Baragwanath 
Hospital from January 1997 to June 1998 were caused by GBS 
(H Saloojee- personal communication). 
The aim of this study was to evaluate the incidence and 
mortality associated with early-onset GBS disease at 
Johannesburg Hospital and to determine whether the Americar 
Academy of Pediatrics (AAP) and American College of 
Obstetricians and Gynecologists (ACOG) recommendations for 
prophylaxis of GBS'" are appropriate for the local situation . 
S UBJECTS AND METHO DS 
This was a descriptive study done at Johannesburg Hospital. 
Approximately 7 800 pregnant women deliver each year at this 
hospital. Subjects were all neonates with a positive blood or 
cerebrospinal fluid (CSF) culture for GBS. Infants were 
identified from laboratory records. The hospital files of both 
neonates and mothers were reviewed retrospectively from 
January 1995 to December 1997 and collected prospectively 
from January 1998 to October 1998. Demographic data, 
admission to the neonatal intensive care unit (NICU), mode of 
delivery, symptoms and signs of illness and short-term 
outcome were collected for all subjects. Maternal da ta included 
age and risk factors for GBS, viz. fever, prolonged rupture of 
membranes (PROM), urinary tract infections (UTI), preterm 
delivery and previous GBS history.3 Babies born outside 
Johannesburg Hospital were excluded from the study. 
Data were captured on the Epi-Info version 6.0 program. 
Standard statistical tests were used to analyse the data. 
Continuous variables were described using means and 
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andard deviations (SDs), while categorical variables were 
escribed using percentages and frequencies. 
{ ESULTS 
here was a total of 33 neonates wi th GBS infection d uring the 
u dy period . The mean birth weight was 2 100 g (SD 763.7 g, 
mge 1 005 - 3 600 g), with 24 of the 33 subjects (72%) having a 
.rth weight less than 2 500 g. The mean gestational age was 35 
eeks (SD 4.02, range 25 - 42 weeks) and 23 of the 33 subjects 
0%) were born prematurely. The mean Apgar scores were 
38 at 1 minute, 7.17 at 5 minutes and 7.9 at 10 minutes. 
The incidence of early-onset GBS disease showed a 
gnificant increase in 1998 compared with the 3 preceding 
~ars (Table I). The clinical presenta tion was pneumonia 
.3/33), septicaemia (6 / 33) and meningitis (4 / 33). A number of 
Jants had GBS infection in more than one site. A total of 
~/33 of the subjects had positive blood cultures; of these, 7 
·esented with septicaemia and pneumonia, while 4 presented 
ith meningitis and septicaemia. Twen ty subjects (60%) 
·quired admission to the JICU. The initial clinical diagnoses 
1 admission to the NICU are given in Table II. The mortality 
te was 12 of all NICU admissions (60%), and the causes of 
eath are shown in Table III. 
Mean maternal age was 24.4 years (range 18-33 years). 
leven of the 33 women had not received antenatal care. There 
ere maternal risk fac tors (as listed above) for GBS in 24 of the 
'\ pregnancies. Risk fac tors included prematurity (23), PROM 
'}, maternal UTI (2) and maternal pyrexia (1). A number of 
regnancies had more than one risk factor. A history of early-
"1Set GBS disease in a previous infant was not recorded in any 
Table I. Incidence of GBS infection by year 
Incidence (/ total no. Incidence (/1 000 
Year of live births) live births) 
1995 5/ 7195 0.69/ 1 ()()() 
1996 5/ 7 979 0.62/1 ()()() 
1997 7/ 7 97 0. 9/1 ()()() 
199 16/ 5353 "2.90/ 1 ()()() 
'Chi-square statistic 192503, 3 degrees of freedom, P-value 0.~4 ~mpared with 
Previous years. Log linear model shows that cases in 1999 were s•gnificanUy higher 
than in previous years. 
Table II. Primary clinical presentation of neonates with GBS 
admitted to the NICU 
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4/ 12 (33) 
4/ 12 (33) 
2/ 12 (16) 
1/ 12 ( ) 
1/1 2 ( ) 
of the cases. There were no risk factors in 9 of 33 pregnancies 
(27%). 
D ISCUSSION AND CONCLUSION 
Early-onset GBS is an ongoing problem at the Joharmesburg 
Hospital as shown in the above tudy, the overall incidence 
being 1.1/ 1 000 live births. There was an increase in the 
incidence of early-onset GBS at Johannesburg Ho pita! d uring 
1998 (2.9/1 000 live bir ths) compared with previou years 
(0.63 - 0. / 1 000 live births). Thi may reflect the fact tha t da ta 
were collected retro pectively during the previous year and 
some case may have been missed . However, an independent 
pro pective urvey of bacterial infection in 1997 confirmed the 
same incidence of GBS disease.' There were no obvious rea ons 
for this increase in incidence during 199 and it may merely 
reflect natural fl uctuation in annual figure . A fl uctuating 
incidence of GBS was also noted in the Oxford tudy.' 
Early-onset GB can be prevented by intrapartum 
chemoprophylaxis to the mother. The AAP and ACOG have 
made recommendations based on combining two strategie : 
culture screening for GBS ca rriage at 35- 37 weeks' ge tation, 
or the pre ence on admi ion for delivery of on or more risk 
fac tors for neona tal GBS disea e (i.e. previous infant wi th 
invasive GBS disea e, GBS bacteriuria during th.i pregnancy, 
gestation < 37 weeks, duration of membrane rupture > 18 
hours, or intrapartum fever >3 °C}.' A modified algorithm for 
prevention of early-onset GBS disea using culture-based 
screening is reproduced in Fig. 1. The Center for Disease 
Control (CDC) recommend either a culture-based approach or 
one based only on risk factor . The CDC recommend that 
cultures be performed at 35- 37 weeks' gestation, which has 
better predictive value for the presence of GBS at term than the 
cultures performed earlier in gestation (26- 2 weeks). It ha 
been estimated that this strategy result in intrapartum 
treatment of 27% of women and prevents up to 6% of early-
onset GBS disease. The strategy based on risk factor only 
resul t in intrapartum treatment of 1 % of women and 
prevents 69% of early-onset GBS disease.' It ~s dear, however, 
that any scheme for prophylaxis will fail to prevent all cases of 
GBS. Approximately 25% of infants with early-onset GBS 
disease have no identifiable risk factors for infection (27% in 
this study).• In addition, for intrapartum therapy to be 
succe ful, antibiotics need to be administered to the mother at 
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Prevention Strategy 
Combined AAP/ACOG guidelines 
Risk factors: 
• Previous infant with invasive GBS 
disease? 
• GBS bacteriuria this pregnancy? 
• Delivery < 37 weeks' gestation 
No------ -------------- Yes 
Vaginal and rectal swab 













Intrapartum temperature;;:, 38°C 
Membrane rupture;;:, 18 hours ----No Yes 
Fig. 1. Guidelines for prevention strategy (combined AAP/ACOG). 
least 4 hours before delivery. Known GBS cases are often 
delivered too quickly for chemoprophylaxis to be effective. 
Also there is concern about penicillin allergy and anaphylaxis; 
however, erythromycin is a suitable alternative.10 
The present survey showed a high mortality rate (60%) and 
frequent number of ICU admissions in comparison with other 
data,11•12 which would appear to justify the need for intrapartum 
GBS prophylaxis. It has been suggested that prevention 
strategies would not be warranted if the incidence of early-
onset GBS disease is below 0.6/ 1 000 live births.12 All 
prevention strategies have been shown to be cost eHective 
compared with no strategy, but the cheapest is the one based 
on risk factors alone without culture screening.13 
Health care in a developing country with limited resources 
is a question of priorities. The AIDS epidemic and the issue of 
vertical transmission of HN over shadows other health 
problems such as GBS infection that are far less prevalent. We 
feel, however, that the incidence of GBS infection is sufficiently 
high to be cause for concern and that a programme of 
intrapartum prophylaxis based on risk factors would be cost 
beneficial. From a neonatal perspective, any simple measure 
that avoids ICU admission and prevents neonatal death and 
handicap is worthwhile. We agree that routine culture-based 
screening of all pregnant women for GBS at 28 weeks is too 
costly to be implemented. A culture-based programme would 
cost the Johannesburg Hospital approximately RIO million per 
annum, based on R132 per patient for rectal, vaginal and urine 
cultures on all antenatal patients. A programme based on risk 
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factors would be aHordable. Most of the pregnant women with 
GBS risk factors such as PROM or maternal pyrexia are treated 
with antibiotics in our obstetric unit and hence would not 
require additional chemoprophylaxis and would not add to the 
cost. The cost of a GBS prophylaxis programme would 
therefore be determined by the additional use of intrapartum 
penicillin in women with uncomplicated preterm delivery. 
During the study period there were a total of 3 460 preterm 
deliveries - assuming that most women would have received 
three doses of penicillin (i.e. delivered within 24 hours), at R3 
per dose the cost of the GBS prophylaxis would have been 
R31 140. Previous prophylactic programmes have prevented 
69% of ICU admissions. It is possible that some of the infants 
may have required NICU on the basis of prematurity and not 
GBS. It is therefore assumed that our GBS prophylaxis would 
prevent 50% of ICU admissions or 40 NICU days at Rl 300 per 
day (total R52 000). The overall saving would have been 
R20 860. The cost of level 2 neonatal care is not considered as 
these babies were delivered preterm and would have been 
hospitalised for prematurity, even in the absence of GBS. The 
prematurity would r.ot have been prevented by the GBS 
prophylaxis. The cost of neonatal care in the public sector is not 
well established; the above figure of Rl 300 per day is derived 
from a recent cost analysis of the neonatal unit at the 
Johannesburg Hospital 0 Flett - unpublished data). Another 
important issue is that 12 of these babies died and some of 
these deaths may have been prevented by GBS prophylaxis. 
In conclusion, we feel that a programme of GBS prophylaxis 
based on risk factors would be beneficial in our hospital. 
Whether all units should adopt a similar approach would 
depend on their own rates of GBS infection. 
The authors wish to thank Patricia Kellet for providing the 
laboratory records and Jacky Galpin for her assistance with the 
statistics. 
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